ARTICLE | Management Tracks
Odyssey hires Jason Haas as CFO
Plus: CMO changes at Centessa, Lifordi, Rapport and Gemma, and updates from Peptone, Labgenius, Mitorx and more
January 10, 2025 2:24 AM UTC
Autoimmune and inflammatory disease company Odyssey Therapeutics Inc. hired Jason Haas as CFO. Haas was CFO of Syros Pharmaceuticals Inc. (NASDAQ:SYRS) and co-head of Americas, healthcare investment banking at Barclays. Odyssey raised a $101 million, Ascenta Capital-led series C round in December 2023.
Four companies, Centessa Pharmaceuticals plc (NASDAQ:CNTA), Lifordi Immunotherapeutics Inc., Rapport Therapeutics Inc. and Gemma Biotherapeutics Inc. named new CMOs. ...